Open AccessThe steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals
Author(s) -
Rolf P. G. van Heeswijk,
Agnes I. Veldkamp,
J. Mulder,
Pieter L. Meenhorst,
Ferdinand W.N.M. Wit,
Joep M. A. Lange,
Sven A. Danner,
Norbert A. Foudraine,
Marthin O. Kwakkelstein,
Peter Reiss,
Jos H. Beijnen,
Richard M. W. Hoetelmans
Publication year - 2000
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-200005260-00001
Subject(s) - cmin , nevirapine , cmax , pharmacokinetics , regimen , dosing , volume of distribution , pharmacology , medicine , human immunodeficiency virus (hiv) , viral load , immunology , antiretroviral therapy
To investigate and to compare the steady-state plasma pharmacokinetics of nevirapine in a dosing regimen of 400 mg once daily versus 200 mg twice daily in HIV-1-infected individuals.